IRIS
FALASCA, KATIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.409
EU - Europa 3.109
AS - Asia 1.264
SA - Sud America 7
Continente sconosciuto - Info sul continente non disponibili 5
Totale 7.794
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.396
IE - Irlanda 677
CN - Cina 645
IT - Italia 572
SE - Svezia 516
UA - Ucraina 512
TR - Turchia 349
GB - Regno Unito 289
FR - Francia 200
DE - Germania 167
IN - India 127
FI - Finlandia 99
KR - Corea 86
VN - Vietnam 30
NL - Olanda 19
BE - Belgio 15
RO - Romania 11
CA - Canada 9
HK - Hong Kong 7
CH - Svizzera 6
AT - Austria 5
SG - Singapore 5
EU - Europa 4
IL - Israele 4
RU - Federazione Russa 4
AR - Argentina 3
BR - Brasile 3
BG - Bulgaria 2
EE - Estonia 2
ES - Italia 2
HR - Croazia 2
HU - Ungheria 2
ID - Indonesia 2
IR - Iran 2
MX - Messico 2
PL - Polonia 2
RS - Serbia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BN - Brunei Darussalam 1
CL - Cile 1
GT - Guatemala 1
JP - Giappone 1
KH - Cambogia 1
LI - Liechtenstein 1
ME - Montenegro 1
MK - Macedonia 1
MM - Myanmar 1
MY - Malesia 1
PA - Panama 1
PH - Filippine 1
TW - Taiwan 1
Totale 7.794
Salva come PNG Salva come JPEG
Città #
Chandler 786
Jacksonville 702
Dublin 660
Princeton 320
Southend 248
Nanjing 217
Izmir 198
Ashburn 177
Altamura 141
Chieti 109
Beijing 108
Dearborn 108
Wilmington 104
Cambridge 98
Ann Arbor 87
Nanchang 65
Boardman 52
Shenyang 37
New York 34
Pune 32
Dong Ket 30
Hebei 27
Seattle 27
Tianjin 27
Washington 27
Jiaxing 25
Kunming 24
Woodbridge 24
Changsha 20
Hangzhou 19
Dallas 17
Norwalk 17
Pescara 17
Grevenbroich 16
Rome 16
Brussels 14
Jinan 14
Changchun 13
Augusta 12
Helsinki 10
Milan 10
Falls Church 9
San Mateo 9
Orange 8
San Vito Chietino 8
Tappahannock 8
Guangzhou 7
Lanzhou 7
Ningbo 7
Edinburgh 6
Hong Kong 6
Houston 6
Toronto 6
Hefei 5
Vienna 5
Albenga 4
Andover 4
Aquila 4
Auburn Hills 4
Campobasso 4
Leawood 4
London 4
Montesilvano 4
Novara 4
Putignano 4
Singapore 4
Chengdu 3
Chicago 3
Francavilla Al Mare 3
Gela 3
Giulianova 3
L'aquila 3
Lanciano 3
Molise 3
Monmouth Junction 3
Mumbai 3
Napoli 3
New Delhi 3
Redwood City 3
Simi Valley 3
Taranto 3
Venafro 3
Zhengzhou 3
Antalya 2
Baotou 2
Bari 2
Belgrade 2
Berazategui 2
Bronte 2
Francavilla al Mare 2
Frankfurt am Main 2
Fuzhou 2
Jakarta 2
Kirkland 2
Los Angeles 2
Malatya 2
Messina 2
Mexico City 2
Orsogna 2
Padova 2
Totale 4.915
Salva come PNG Salva come JPEG
Nome #
Study of immune alterations in patients with Chronic Fatigue Sindrome with different etiologies 96
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 96
Relevance of plant lectins in human cell biology and immunology 96
Effect of probiotic supplement on cytokine levels in HIV-infected individuals: A preliminary study 94
Metabolic modifications in HIV-infected women 89
STUDIO CLINICO MULTICENTRICO PER LA VALUTAZIONE DELLA MICROALBUMINURIA NEI PAZIENTI CON INFEZIONE DA HIV 88
Cytokine patterns correlate with liver damage in patients with chronic hepatitis B and C. 86
The impact of homocysteine, B12, and D vitamins levels on functional neurocognitive performance in HIV-positive subjects 86
Dual nucleoside therapy for HIV infection: analysis of results and factors influencing viral response and long term efficacy 85
Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA project 85
Long term effect of telmisartan in HIV-positive male patients with high blood pressure 84
Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort 84
Cytomegalovirus infection in heart-transplants recipients, in a central region of Italy 84
Cytokines, Hepatic Fibrosis, and Antiretroviral Therapy Role in Neurocognitive Disorders HIV Related 84
Interleukin-4 and interferon-gamma production during HIV-1 infection and changes induced by antiretroviral therapy. 82
Association between plasma interleukin-18 levels and liver injury in chronic hepatitis C-virus infection and non-alcoholic fatty liver disease. 81
Long term effect of switching to darunavir/ritonavir in HIV infected patients previously on protease inhibitor therapy 80
Antidepressant therapy can improve adherence to antiretroviral regimens among HIV-infected and depressed patients. 79
Associations between hypertriglyceridemia and serum ghrelin, adiponectin, and IL-18 levels in HIV-infected patients. 75
Quality of life, depression and cytokine patterns in patients with chronic hepatitis C treated with antiviral therapy. 74
Cancer risk and use of protease inhibitor or nonnucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy: The D:A:D study 74
Durability of first-line regimens including integrase strand transfer inhibitors (INSTIs): data from a real-life setting 73
Cystatin C, adipokines and cardiovascular risk in HIV infected patients. 72
Circulating CD40 ligand, Dickkopf-1 and P-selectin in HIV-infected patients 72
Cardiac Toxicity Associated with HCV Direct Antiviral Agents 71
Treatment with silibyn- Vitamin E- Phospholipid complex in patients with Hepatitis C infection. 70
Use of epoetin beta during combination therapy of infection with hepatitis c virus with ribavirin improves a sustained viral response. 70
Hypertension in HIV: Management and Treatment 69
Could S-100b be a marker of the neurologic involvement in HIV-affected patients? 67
Methicillin-resistant staphylococcus epidermidis (MRSE) endocarditis treated with linezolid 67
Acute urinary retention due to HSV-1: a case report 67
Beneficaial effects of telmisaratan in HIV+ diabetic insulin-dependent patient 67
Effetti del trattamento con vitamina E sulla sintomatologia muscolo-scheletrica soggettiva ed oggettiva della Sindrome da Fatica Cronica 67
Is the rate of virological failure to cART continuing to decline in recent calendar years? 67
The proinflammatory interleukin-21 elicits anti-tumor response and mediates autoimmunity 66
Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimen 66
Short communication: Proangiogenic hematopoietic cells in acute HIV infection 65
Duration of COVID-19: Data from an Italian Cohort and Potential Role for Steroids 65
Interleukin-31: a new cytokine involved in inflammation of the skin 64
High dose of erythropoietin in management of interferon/ribavirin induced anemia 64
Safety and tolerability of Elvitegravir/ Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project 64
Metabolic syndrome and cardiovascular risk in HIV-infected patients with lipodystrophy. 63
Inguinal lymphadenopathy due to Bartonella henselae 63
Effetti del trattamento con vitamina e sulla sintomatologia muscoloscheletrica soggettiva ed oggettiva della sindrome da fatica cronica 63
Antiretroviral therapy management and rationalisation of available resources 63
Use of quantitative ultrasound as bone mineral density evaluation in an Italian female population living with HIV: A real-life experience 63
Switch to rilpivirine improves diabetes in an elderly HIV-positive patient 63
Antihypertensive and metabolic effects of telmisartan in hypertensive HIV-positive patients 62
Improved metabolic profile after switch to darunavir/ritonavir in HIV positive patients previously on protease inhibitor therapy. 62
Predictive factors and prevalence of microalbuminuria in HIV-infected patients: a cross-sectional analysis 62
Canakinumab in a subgroup of patients with COVID-19 62
Periodontitis and cytokine patterns in HIV positive patients 61
Ruolo delle citochine nella patogenesi delle malattie infettive 61
Use of hematopoietic growth factor in the management of hematological side effects associated to antiviral treatment for HCV hepatitis. 61
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus 61
Probiotics and anti-inflammatory processes in HIV infection: from Benchside Research to Bedside 61
Air and surface measurements of SARS-CoV-2 inside a bus during normal operation 61
HIV-RNA decay in paired blood and semen samples of subjects receiving their first dolutegravir-based ART regimen 60
Proteinuria in an African HIV-infected patient: effects of telmisartan. 59
Normal breathing releases SARS-CoV-2 into the air 59
Increased production of oncostatin-M by lymphomononuclear cells from HIV-1-infected patients with neuroAIDS. 58
Severe HIV-associated hypertriglyceridemia treated with rosuvastatin plus mega-3 fatty acids 58
Induction with ribavirin in a relapsing patient with chronic HCV hepatitis. 58
Different strategies of 25OH vitamin D supplementation in HIV+ subjects. 58
Effectiveness of first-generation HCV protease inhibitors: does HIV coinfection still play a role? 58
Correlation between neurocognitive disorders and pattern cytokines in HIV+ patients 58
Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort 58
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004-2014 58
Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study. 57
Prevalence of anal, oral, penile and urethral Human Papillomavirus in HIV infected and HIV uninfected men who have sex with men 57
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: Data from the ICONA cohort 57
IL-1beta induces alkaline phosphatase in human phagocytes 56
Infected atrial mixoma: a rare cause of fever 56
Esophagitis and anticonvulsant hypersensitivity syndrome. 56
Microalbuminuria and hypertension in HIV-infected patients: a preliminary study of telmisartan. 56
Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: The D: A: D study 56
IL-15 an immunoregulatory and anti-cancer cytokine. Recent advances 55
Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4+ cell count. 54
Triglyceride/HDL ratio and its impact on the risk of diabetes mellitus development during ART 54
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: An observational cohort study 54
Favourable evolution of virological and immunological profiles in treated and untreated patients in Italy in the period 1998-2008. 53
Inflammatory cytokines and S-100b protein in patients with hepatitis C infection and cryoglobulinemias 53
Incidence of malignancies in HIV-infected patients and prognostic role of current CD4 cell count: evidence from a large Italian cohort study. 53
Effect of antiviral therapy on pro-angiogenic hematopoietic and endothelial progenitor cells in HIV-infected people. 53
Risk of clinical progression among patients with immunological nonresponse despite virological suppression after combination antiretroviral treatment. 52
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/m 52
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 52
Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D Study 52
Role of serum free light chains in predicting HIV-associated non-Hodgkin lymphoma and Hodgkin's lymphoma and its correlation with antiretroviral therapy. 51
Relationship between musculoskeletal symptoms and blood markers of oxidative stress in patients with chronic fatigue syndrome 51
Associations between immune depression and cardiovascular events in HIV infection. 51
Incidence and factors associated with the risk of sexually transmitted diseases in HIV-infected people seen for care in Italy: Data from the Icona Foundation cohort 51
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: an observational cohort study 51
First‐line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 51
Prevalence of hypovitaminosis D and factors associated with vitamin D deficiency and morbidity among HIV-infected patients enrolled in a large Italian cohort. 50
Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus 50
Prevalence of HPV infection among HIV-positive and HIV-negative women in central/eastern Italy: Strategies of prevention 50
BNT162b2 mRNA vaccination leads to long-term protection from COVID-19 disease 50
Pidotimod and Immunological Activation in Individuals Infected with HIV 49
Clinical characteristics and cardiovascular implications of the dead patients for COVID-19 49
Totale 6.461
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.388
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.388
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019285 0 0 0 0 0 0 0 0 0 10 43 232
2019/20201.687 503 99 26 34 140 109 181 140 82 173 174 26
2020/2021865 124 6 154 18 73 171 33 24 58 83 52 69
2021/2022776 27 24 11 157 47 17 30 57 57 28 81 240
2022/20232.331 209 363 139 242 206 443 132 175 254 27 67 74
2023/20241.026 77 50 89 44 100 332 264 58 9 3 0 0
Totale 8.556